설명
Study design and participant disposition for the 52-week double-blind randomized trial of bitopertin as adjunctive treatment in Japanese patients with schizophrenia are depicted.
Fig. 1
FlowchartSource Paper
A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese …Cite This Figure
 > Source: Yoshio Hirayasu et al. "A double-blind randomized study assessing safety and efficacy following one-year." *BMC psychiatry*, 2016. PMID: [26980460](https://pubmed.ncbi.nlm.nih.gov/26980460/)
<figure> <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791769/bin/12888_2016_778_Fig1_HTML.jpg" alt="Study design and participant disposition for the 52-week double-blind randomized trial of bitopertin as adjunctive treatment in Japanese patients with schizophrenia are depicted." /> <figcaption>Fig. 1. Study design and participant disposition for the 52-week double-blind randomized trial of bitopertin as adjunctive treatment in Japanese patients with schizophrenia are depicted.<br> Source: Yoshio Hirayasu et al. "A double-blind randomized study assessing safety and efficacy following one-year." <em>BMC psychiatry</em>, 2016. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/26980460/">26980460</a></figcaption> </figure>